M.D. Anderson Cancer Center: all 3,044 studies

Page 16 of 31. Open to participants first (578), then studies with results posted, then the rest; newest registration first within each.

• A Phase II Study of Neoadjuvant Sacituzumab Govitecan and Pembrolizumab Therapy for Immunochemotherapy-resistant Early-stage Triple-negative Breast Cancer (TNBC)Active, not recruitingNCT05675579Phase 2
• A Safety And Efficacy Study Of HLA-G- Targeted CAR-T Cells IVS-3001 In Subjects With Previously Treated Advanced HLA-G-Positive Solid TumorsActive, not recruitingNCT05672459Phase 1/2
• Phase I/II Open Label Study Evaluating the Safety and Efficacy of Combining STAT3 Inhibition (TTI-101) With Anti-PD-1 Therapy (Pembrolizumab) in Patients With Recurrent or Metastatic (RM) Head and Neck Squamous Cell Carcinoma (HNSCC)WithdrawnNCT05668949Phase 1/2
• Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCCSuspendedNCT05663710Phase 1/2
• Perceptions on Expected Outcomes of Immunotherapy in Advanced Cancer Patients With Poor Performance StatusCompletedNCT05634551
• Phase Ib Trial of the KRASG12C Inhibitor Adagrasib (MRTX849) in KRAS G12C Mutant Metastatic Pancreatic Cancer PatientsWithdrawnNCT05634525Phase 1
• Phase 1b Study of EZH1/2 Inhibitor Valemetostat in Combination With Trastuzumab Deruxtecan in Subjects With HER2 Low/Ultra-low/Null Metastatic Breast CancerActive, not recruitingNCT05633979Phase 1
• A First-In-Human Phase 1 Trial of T-Cell Membrane-Anchored Tumor Targeted Il12 (Attil12)- T-Cell Therapy in Subjects With Advanced/Metastatic Soft Tissue and Bone SarcomaActive, not recruitingNCT05621668Phase 1
• Feasibility, Safety, and Efficacy of Stereotactic MRI-Guided Adaptive Radiation Therapy (SMART) for Central Lung TumorsTerminatedNCT05609331Not applicable
• A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Tolerant Users Undergoing Surgery to Reduce Post-operative Opioid UseWithdrawnNCT05589857Phase 2
• Impact of High Dietary Fiber on Microbiome and Vaccine ResponsesActive, not recruitingNCT05565586Not applicable
• A Virtually Delivered Exercise Intervention To Mitigate Cognitive Deficits From Radiotherapy In AYAs With Brain TumorsTerminatedNCT05554159Not applicable
• E-Health Support Program (PACK Health Program) in Supporting Patient Reported Symptoms in Newly Diagnosed Patients With Breast CancerCompletedNCT05549687Not applicable
• Phase 2 Study of Neoadjuvant SAR444245 Plus Cemiplimab in HPV Related Oropharynx Squamous Cell CarcinomaWithdrawnNCT05535023Phase 2
• The Attitudes and Beliefs of Hispanic/Latino Individuals Toward Prescription Opioids and Non-Medical Opioid UseWithdrawnNCT05529082
• STI-6129 CD38 ADC for the Treatment of Patients With Relapsed or Refractory Systemic ALL AmyloidosisWithdrawnNCT05519527Phase 1
• Simulation-Based Caregiving Skills Training for Family Members of High Grade Glioma PatientsActive, not recruitingNCT05511324Not applicable
• Phase Ib Trial of Infigratinib In Combination With Atezolizumab And Bevacizumab for The Second-Line Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion/AmplificationWithdrawnNCT05510427Phase 1
• Phase 1b/2 Trial of Ipilimumab, Nivolumab, and Ciforadenant (Adenosine A2a Receptor Antagonist) in First-line Advanced Renal Cell Carcinoma.Active, not recruitingNCT05501054Phase 1/2
• A Phase 1b Study of Gemcitabine and Nab-paclitaxel in Combination With IM156 in Patients With Advanced Pancreatic Cancer.Active, not recruitingNCT05497778Phase 1
• Survey Assessment of Patient and Provider Impressions of Telemedicine in Radiation OncologyActive, not recruitingNCT05496972
• A Pilot "Window-3" Study of Acalabrutinib Plus Rituximab Followed by Brexucabtagene Autoleucel Therapy in Patients With Previously Untreated High-risk Mantle Cell LymphomaActive, not recruitingNCT05495464Early Phase 1
• A Feasibility and Acceptability Pilot Study Evaluating a Patient-Specific Targeted Intervention Using Patient Navigators or Routine Clinical CareWithdrawnNCT05488444Phase 2
• Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced CancerActive, not recruitingNCT05474846Phase 2/3
• Use of Water Warming/Cooling Garment to Maintain a Constant Intraoperative Core Target Temperature in Patients Undergoing Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Proof-of-Concept StudyWithdrawnNCT05474352Early Phase 1
• Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic MelanomaActive, not recruitingNCT05470283Phase 1
• A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Naïve Undergoing Surgery to Reduce Postoperative Opioid Use (GAMING-ON Study)CompletedNCT05466994Phase 2
• Feasibility of Combined Genomics/Transcriptomics for Patients With LymphomaActive, not recruitingNCT05464823Not applicable
• Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and CaregiversActive, not recruitingNCT05436327Not applicable
• Phase I Study of ZN-c3 and Bevacizumab ± Pembrolizumab in Metastatic CCNE1 Amplified and TP53 Mutant Solid TumorsWithdrawnNCT05431582Phase 1
• A Pilot Study Assessing the Effectiveness of Use of Guided Imagery for Treatment of Pain and Symptom Management in Women With Post-mastectomy Pain SyndromeCompletedNCT05408741Not applicable
• Neoadjuvant PD-1 Plus TIGIT Blockade in Patients With Cisplatin-Ineligible Operable High-Risk Urothelial CarcinomaActive, not recruitingNCT05394337Phase 1/2
• A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast CancerActive, not recruitingNCT05394259Phase 1
• BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer PatientsWithdrawnNCT05363709Phase 2
• Stereotactic Liver Ablation Assisted With Intra-Arterial CT Hepatic Arteriography and Ablation Confirmation Software Assessment (STEREOLAB)Active, not recruitingNCT05361551Not applicable
• Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in MozambiqueActive, not recruitingNCT05359016Not applicable
• Innovative Treatment of Chemotherapy-Induced Painful Peripheral Neuropathy in Adolescents and Young Adults With Cancer: A Two Arm Pilot StudyActive, not recruitingNCT05357469Not applicable
• The Effects of Spiritual Needs on Spiritual Well-Being in Patients With Brain Tumors: A Structural Equation Modeling ApproachWithdrawnNCT05356507
• Phase II Trial of Immunotherapy in Patients With Carcinomas Arising From the Renal MedullaActive, not recruitingNCT05347212Phase 2
• TAS-102 With or Without Celecoxib in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant ChemotherapyActive, not recruitingNCT05343013Phase 2
• A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare CancersSuspendedNCT05337735Phase 2
• Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple MyelomaActive, not recruitingNCT05336383Phase 2
• A Phase 2 Study to Evaluate the Triplet Combination of Pemetrexed Plus AB928 (Etrumadenant) + AB122 (Zimberelimab) in Patients With Previously Treated Advanced or Metastatic MTAP Deficient Urothelial CarcinomaActive, not recruitingNCT05335941Phase 2
• Attitudes and Believes About Vaccinations in a Supportive Care Patient PopulationCompletedNCT05329506
• Non-randomized, Open-label Study of Intralesional Nivolumab for High Risk Oral Premalignant LesionsActive, not recruitingNCT05327270Phase 1
• A Pilot Study of Glutamine PET Imaging of Head and Neck Squamous Cell CarcinomaTerminatedNCT05322135Early Phase 1
• Pirtobrutinib (LOXO-305) Consolidation for MRD Eradication in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL) Treated With VenetoclaxTerminatedNCT05317936Phase 1/2
• POWER UP: Participating Online While Exercising to Recover Using PlayTerminatedNCT05308407Not applicable
• Barriers and Facilitators in Access to OT/PT in Pediatric Cancer SurvivorsActive, not recruitingNCT05305950
• Pharmacologic Pretransplant Immunosuppression (PTIS) + Reduced Toxicity Conditioning (RTC) Allogeneic Stem Cell Transplantation in Inherited Hematologic DisordersWithdrawnNCT05293509Phase 2
• Development of an Application-Based Digital Navigator for Perioperative Breast Surgery PatientsCompletedNCT05290402
• A Phase II Study of Vibecotamab (XmAb14045) for MRD- Positive AML and MDS After Hypomethylating Agent FailureTerminatedNCT05285813Phase 2
• A Pilot Study to Assess Changes in Tumor Biology Following Second-line Treatment With Pembrolizumab Plus Lenvatinib in Patients With Advanced Pancreatic Ductal AdenocarcinomaCompletedNCT05273554Phase 1
• A Phase II Study of the Combination of Ponatinib With Mini-hyper CVD Chemotherapy and Venetoclax in Patients With Relapsed or Refractory T-cell Acute Lymphoblastic LeukemiaTerminatedNCT05268003Phase 2
• Association Between Gut Microbiome and Dietary Determinants and Vaccine ResponseActive, not recruitingNCT05239403
• A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast CancerActive, not recruitingNCT05226663Phase 2
• A Mobile Phone Text-based Intervention to Reduce Sedentary Behavior and Engage Communities on the Importance of Healthy Lifestyles: the TEXT2MOVE StudyActive, not recruitingNCT05217108Not applicable
• Oncology Dashboard for the Improvement of Operational Efficiency and Patients Outcomes in Patients With SarcomaCompletedNCT05216029Not applicable
• Liver Cancer Prevention Randomized Control TrialActive, not recruitingNCT05196867Not applicable
• Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast CancerWithdrawnNCT05177796Phase 2
• 18F-FDG PET-MRI for Planning and Follow-Up of Patients With Spine Tumors Treated With Spine Stereotactic RadiosurgeryCompletedNCT05174026Not applicable
• Mobility and Physical Activity in Adolescent and Young Adult Cancer Patients or Survivors at Risk for Cardiovascular Morbidity and Frailty, The MOBILE AYA StudyWithdrawnNCT05169151
• A Prospective Study of Performing MRI Simulation in Treatment Position in Spinal Stereotactic Body Radiation TherapyActive, not recruitingNCT05155423
• A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the BladderActive, not recruitingNCT05137262Phase 2
• Mobile-Health Delivery of Lifestyle Interventions for Women With Breast CancerActive, not recruitingNCT05132296Not applicable
• GRAvity- Versus Wall Suction-drIven Large Volume Thoracentesis: a RAndomized Controlled Study (GRAWITAS Study)CompletedNCT05131945Not applicable
• Patient-Specific Decision Aid System for Shared Decision Making About Breast ReconstructionActive, not recruitingNCT05130580Not applicable
• 4-Point Therapy Response Score With PET/CT for Anal Squamous Cell CancerCompletedNCT05130073
• 3D Printed Oral Stents for Patients With Head and Neck Cancer Receiving Radiation TherapyTerminatedNCT05126797Not applicable
• Monitoring Your Exercise-related Metrics Over Time Via Wearable Electronic DevicesActive, not recruitingNCT05124405Not applicable
• A Phase 1a/1b Study to Determine the Recommended Phase 2 Dose, of Tepotinib in Participants With MET Alterations and Brain TumorsWithdrawnNCT05120960Phase 1
• A Phase II Study of Neoadjuvant Sotorasib in Combination With Cisplatin or Carboplatin and Pemetrexed for Surgically Resectable Stage IIA-IIIB Non-Squamous Non-Small Cell Lung Cancer With a KRAS p.G12C MutationActive, not recruitingNCT05118854Phase 2
• Single Step Lesion Annotation and Localization of Suspicious Breast LesionsTerminatedNCT05118295Early Phase 1
• Pembrolizumab and Lenvatinib for the Treatment of Serous Ovarian Cancer PatientsActive, not recruitingNCT05114421Phase 2
• Patient Perceptions of the Relational Empathy of Healthcare Practitioners From the Department of Emergency Medicine During the COVID-19 PandemicActive, not recruitingNCT05102656Not applicable
• Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer PatientsTerminatedNCT05101213Phase 1
• Gabapentin for the Reduction of Opiate Use Following Pulmonary Resection (GROUP Trial)WithdrawnNCT05100160Phase 3
• Parent and Family Obesity Intervention in Reducing Obesity Risk in Racial Ethnic Minority FamiliesActive, not recruitingNCT05094466Not applicable
• Patient-Informed Educational Intervention for the Improvement of Cervical Cancer LiteracyWithdrawnNCT05093712
• Magnetic Particle-ICG Lymph Node Mapping in Colorectal CancerWithdrawnNCT05092750Phase 1/2
• Assessment of Verbal Comprehension and Cognitive Processes in Patients Admitted to the Palliative and Supportive Care UnitSuspendedNCT05091632
• MRI and Blood Biomarkers for the Prediction of Neurocognitive Decline Following Brain RadiationTerminatedNCT05087888
• Phase I/II Randomized Study of Stereotactic Ablative Radiotherapy (SABR) Versus Standard of Care for Refractory Structural Cardiac Arrhythmias (SABR-HEART)WithdrawnNCT05084391Phase 1/2
• Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative ChemotherapyCompletedNCT05083338
• Interdisciplinary Interventions to Address Pain Management Among Head and Neck Cancer PatientsActive, not recruitingNCT05077072Phase 2
• Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid TumorsActive, not recruitingNCT05075993Phase 1
• Treatment Decision Making in African American Women Diagnosed With Triple Negative Breast CancerCompletedNCT05071677
• Belantamab Mafadotin Maintenance Therapy After Salvage Autologous Hematopoietic Cell Transplantation in Patients With Relapse Refractory Multiple MyelomaTerminatedNCT05065047Phase 1
• Phase II Study of AK104 (Cadonilimab) for Recurrent Small Cell Neuroendocrine Carcinomas of the CervixActive, not recruitingNCT05063916Phase 2
• Positron Emission Tomography for the Diagnosis of Immune Checkpoint Inhibitor-Related MyocarditisCompletedNCT05062395
• Impact Of Muscle Vibration On Gait ControlActive, not recruitingNCT05061238Not applicable
• Use of Google Translate to Enhance Patient Pain and Nausea Assessment and Satisfaction After General AnesthesiaCompletedNCT05060328
• An Investigational Scan (MR DENSE) in Detecting Early Chemotherapy-Related Liver Injury Before Surgery in Patients With Resectable Colorectal Liver MetastasesWithdrawnNCT05059717Not applicable
• Three-Dimensional Fluoroscopic Guidance During Transbronchial CryobiopsyCompletedNCT05059691
• Distress Associated with Coronavirus Disease 2019 and Telehealth on Supportive Care Patients with Advanced CancerCompletedNCT05058339
• Promoting HPV Vaccination Among Young Adults in TexasActive, not recruitingNCT05057312Not applicable
• Contrast Enhanced Spectral Mammography for the Evaluation of Pathologic Nipple DischargeActive, not recruitingNCT05056844Not applicable
• Multicomponent Physical Activity Intervention for the Reduction of Psychosocial Distress in Cancer PatientsTerminatedNCT05056831Not applicable
• An Exercise and Nutrition Monitoring Intervention (Pt Pal) for the Improvement of Strength in Patients With Pancreatic or Stomach Cancer Receiving Chemoradiation Therapy Before Surgery, SurgeryStrong StudyWithdrawnNCT05056805Not applicable
• PREVENT: PeRomEter Visualization to ENd Treatment-related LymphedemaActive, not recruitingNCT05056207Not applicable

← M.D. Anderson Cancer Center overview and focus areas